JAMES HILL: Open Payments
NPI 1013438969 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 38 payments from 17 companies in 2025. Trend: 2023 $1,293 · 2024 $1,287 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $144 |
| AstraZeneca Pharmaceuticals LP | 4 | $105 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| HARMONY BIOSCIENCES LLC | 2 | $55 |
| Exact Sciences Corporation | 3 | $54 |
| Lilly USA, LLC | 3 | $52 |
| Verona Pharma, Inc. | 2 | $49 |
| Amgen Inc. | 3 | $48 |
| Novo Nordisk Inc | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
Products named: TRELEGY ELLIPTA, Auvelity, AIRSUPRA, WAKIX, MOUNJARO, Ohtuvayre, REXULTI, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
